Breast Cancer Prevention
Breast cancer is a devastating illness that affects tens of thousands of American women each year. Although it is impossible to predict who will develop breast cancer, clinicians can identify women who are at increased risk for breast cancer and provide them with options to reduce their risk. A number of validated, quantitative risk-assessment models incorporate features of a patient’s medical and family history to help women more accurately estimate their individual risk and thus aid them in decision-making. Over the years, research has focused on the development of both surgical and medical methods for breast cancer risk reduction in high-risk women. This chapter will emphasize the importance of identifying and educating women at increased risk for breast cancer, and then providing them with a comprehensive breast cancer risk management plan. We will also discuss the surgical and medical options available and offer a management summary for breast cancer risk reduction.
KeywordsBreast Cancer Breast Cancer Risk Prophylactic Mastectomy Breast Cancer Prevention Breast Cancer Risk Reduction
Unable to display preview. Download preview PDF.
- 3.Vogel, V. G. 1998. Breast cancer risk factors and preventive approaches to breast cancer. In: Kavanagh J, Singletary SE, Einhorn N, et al., editors. Cancer in women. Cambridge (MA): Blackwell Scientific Publications, Inc., 58–91.Google Scholar
- 4.Vogel, VG, Bevers, T. Handbook of Breast Cancer Risk-Assessment. Evidence-Based Guidelines for Evaluation, Prevention, Counseling, and Treatment. Sudbury (MA): Jones and Bartlett Publishers; 2003.Google Scholar
- 14.Fisher, B., Costantino, J. P., Wickerham, D. L., et al. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90:1371–88.Google Scholar
- 29.Cuzick, J., Forbes, J. F., Sestak, I., et al. for the International Breast Cancer Intervention Study (IBIS) I Investigators. 2007. Long-term results of tamoxifen prophylaxis for breast cancer-96 month follow-up of the randomized IBIS-I study. J Natl Cancer Inst 99:272–82.PubMedCrossRefGoogle Scholar
- 44.Vogel, V. G., Costantino, J. P., Wickerham, D. L., et al. 2006. National Surgical Adjuvant Breast and Bowel Project (NSABP). Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA 295:2727–41.PubMedCrossRefGoogle Scholar
- 52.Sherbourne, C. D. 1992. Social functioning: sexual problems measures. In: Stewart AL, Ware JE, editors. Measuring functioning and well-being: The Medical Outcomes Study approach. Durham, NC: Duke University Press, 194–204.Google Scholar